Our Experts

Maria Anschütz

Maria Anschütz, a pharmacist by training, joined SocraTec R&D in 2002. Together with her team – the project managers and the project management assistants – she is responsible for trial protocol development, project management and reporting. With her penchant for perfection, she is a guarantor for inspection-safe study performance and documentation. Very early in her career she scientifically specialised in the field of early phase clinical trials and thus is today responsible for all studies being realised in our Clinical Pharmacology Unit.

André Warnke

André Warnke, a pharmacist by training, joined SocraTec in 2002 as a project manager. Very early it became obvious that his open-mindedness and decision-making courage predestined him for new business fields. Accordingly, he set-up the Brazilian activities of SocraTec R&D and built the path to later phases of clinical trials by establishing a monitoring group at SocraTec. In 2012 he became a management board member and managing director of SocraTec R&D.

Ralph-Steven Wedemeyer

Ralph-Steven Wedemeyer, a pharmacist by training, specialised in pharmaceutical technology during his PhD thesis and joined the SocraTec family in 2007. His biopharmaceutical expertise significantly contributes to the consultancy activities of SocraTec R&D and consequently led to an early and strong focus on pharmacokinetics. Together with Ramon Villalobos-Hernandez and the team at SocraMetrics, he is today responsible for all pharmacokinetic analyses at SocraTec R&D.

Melanie Zillig

Melanie Zillig, a pharmacist by training, joined SocraTec right at the beginning. She already worked with Barbara Schug and Henning Blume at the Zentrallaboratorium Deutscher Apotheker and decided to develop the SocraTec R&D and SocraMetrics QA system from the first steps of the company activities. She is highly experienced in GCP and GLP and extended her knowledge to GMP issues related to Annex -13. Together with her team she is responsible for the entire QA- system, all audit activities, the SOP -system and for accompanying all types of inspections by authorities.

The founders of SocraTec R&D

Henning Blume

Henning Blume, founder of SocraTec and Professor of Pharmacy at the University of Frankfurt, is a highly established expert in the broad field of biopharmaceutics. At SocraTec R&D, he is a valued sparring partner for colleagues when complex and demanding solutions are required. In addition, he supports clients with highly sophisticated consultancy services at SocraTec R&D.

Barbara Schug

Barbara Schug, founder of SocraTec and managing director until 2024, is a pharmacist by training but from the beginning focused on pharmacology to build the bridge between both faculties at SocraTec. Her background very early resulted in including patients in early -phase trials at the SocraTec R&D Clinical Pharmacology Unit and in pushing the development into later stages of clinical trials. After stepping down from her management role in 2024, Barbara Schug continues to be closely connected with SocraTec. In her capacity as an independent consultant, she contributes her expertise to selected projects where her profound methodological experience is of particular value. This cooperation ensures that SocraTec continues to benefit from her long-standing scientific insight while maintaining her independent professional status.

For expertise in Data Management, Statistics, IT and EDC see SocraMetrics.